nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0305	0.332	CbGbCtD
Hydralazine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0284	0.308	CbGbCtD
Hydralazine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.013	0.142	CbGbCtD
Hydralazine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0119	0.13	CbGbCtD
Hydralazine—RYR2—trigeminal ganglion—peripheral nervous system neoplasm	0.0104	0.204	CbGeAlD
Hydralazine—RYR2—brainstem—peripheral nervous system neoplasm	0.00919	0.181	CbGeAlD
Hydralazine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00814	0.0885	CbGbCtD
Hydralazine—AOC3—trigeminal ganglion—peripheral nervous system neoplasm	0.00625	0.123	CbGeAlD
Hydralazine—AOC3—parotid gland—peripheral nervous system neoplasm	0.00589	0.116	CbGeAlD
Hydralazine—P4HA1—trigeminal ganglion—peripheral nervous system neoplasm	0.005	0.0982	CbGeAlD
Hydralazine—P4HA1—parotid gland—peripheral nervous system neoplasm	0.00471	0.0926	CbGeAlD
Hydralazine—RYR2—cerebellum—peripheral nervous system neoplasm	0.00453	0.089	CbGeAlD
Hydralazine—AOC3—cerebellum—peripheral nervous system neoplasm	0.00273	0.0536	CbGeAlD
Hydralazine—P4HA1—cerebellum—peripheral nervous system neoplasm	0.00218	0.0429	CbGeAlD
Hydralazine—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00136	CcSEcCtD
Hydralazine—Chills—Etoposide—peripheral nervous system neoplasm	0.00115	0.00135	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00115	0.00134	CcSEcCtD
Hydralazine—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00134	CcSEcCtD
Hydralazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00115	0.00134	CcSEcCtD
Hydralazine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00134	CcSEcCtD
Hydralazine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00133	CcSEcCtD
Hydralazine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00133	CcSEcCtD
Hydralazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00133	CcSEcCtD
Hydralazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00133	CcSEcCtD
Hydralazine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00132	CcSEcCtD
Hydralazine—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00132	CcSEcCtD
Hydralazine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00132	CcSEcCtD
Hydralazine—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00132	CcSEcCtD
Hydralazine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00113	0.00131	CcSEcCtD
Hydralazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00112	0.00131	CcSEcCtD
Hydralazine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.0013	CcSEcCtD
Hydralazine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.0011	0.00129	CcSEcCtD
Hydralazine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00129	CcSEcCtD
Hydralazine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00128	CcSEcCtD
Hydralazine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0011	0.00128	CcSEcCtD
Hydralazine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00128	CcSEcCtD
Hydralazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00128	CcSEcCtD
Hydralazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00127	CcSEcCtD
Hydralazine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00127	CcSEcCtD
Hydralazine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00127	CcSEcCtD
Hydralazine—Purpura—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00126	CcSEcCtD
Hydralazine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00108	0.00126	CcSEcCtD
Hydralazine—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00126	CcSEcCtD
Hydralazine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00108	0.00125	CcSEcCtD
Hydralazine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00107	0.00125	CcSEcCtD
Hydralazine—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00124	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00124	CcSEcCtD
Hydralazine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00106	0.00124	CcSEcCtD
Hydralazine—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00124	CcSEcCtD
Hydralazine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00123	CcSEcCtD
Hydralazine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00123	CcSEcCtD
Hydralazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00105	0.00123	CcSEcCtD
Hydralazine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00123	CcSEcCtD
Hydralazine—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00122	CcSEcCtD
Hydralazine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00122	CcSEcCtD
Hydralazine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00104	0.00122	CcSEcCtD
Hydralazine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00121	CcSEcCtD
Hydralazine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00121	CcSEcCtD
Hydralazine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00104	0.00121	CcSEcCtD
Hydralazine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00121	CcSEcCtD
Hydralazine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00103	0.00121	CcSEcCtD
Hydralazine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.0012	CcSEcCtD
Hydralazine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00103	0.0012	CcSEcCtD
Hydralazine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00103	0.0012	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00103	0.0012	CcSEcCtD
Hydralazine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00102	0.00119	CcSEcCtD
Hydralazine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00102	0.00119	CcSEcCtD
Hydralazine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00119	CcSEcCtD
Hydralazine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00101	0.00118	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00118	CcSEcCtD
Hydralazine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00101	0.00118	CcSEcCtD
Hydralazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.001	0.00117	CcSEcCtD
Hydralazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00117	CcSEcCtD
Hydralazine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00117	CcSEcCtD
Hydralazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000997	0.00116	CcSEcCtD
Hydralazine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000997	0.00116	CcSEcCtD
Hydralazine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000989	0.00115	CcSEcCtD
Hydralazine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000987	0.00115	CcSEcCtD
Hydralazine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000981	0.00114	CcSEcCtD
Hydralazine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000981	0.00114	CcSEcCtD
Hydralazine—Rash—Topotecan—peripheral nervous system neoplasm	0.000981	0.00114	CcSEcCtD
Hydralazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00098	0.00114	CcSEcCtD
Hydralazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00098	0.00114	CcSEcCtD
Hydralazine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000976	0.00114	CcSEcCtD
Hydralazine—Headache—Topotecan—peripheral nervous system neoplasm	0.000975	0.00114	CcSEcCtD
Hydralazine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000973	0.00114	CcSEcCtD
Hydralazine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000973	0.00114	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000973	0.00114	CcSEcCtD
Hydralazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000973	0.00113	CcSEcCtD
Hydralazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000972	0.00113	CcSEcCtD
Hydralazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000972	0.00113	CcSEcCtD
Hydralazine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000969	0.00113	CcSEcCtD
Hydralazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000967	0.00113	CcSEcCtD
Hydralazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000967	0.00113	CcSEcCtD
Hydralazine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000964	0.00112	CcSEcCtD
Hydralazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000964	0.00112	CcSEcCtD
Hydralazine—Rash—Melphalan—peripheral nervous system neoplasm	0.00096	0.00112	CcSEcCtD
Hydralazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00096	0.00112	CcSEcCtD
Hydralazine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00095	0.00111	CcSEcCtD
Hydralazine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000941	0.0011	CcSEcCtD
Hydralazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000931	0.00109	CcSEcCtD
Hydralazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000929	0.00108	CcSEcCtD
Hydralazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000929	0.00108	CcSEcCtD
Hydralazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000925	0.00108	CcSEcCtD
Hydralazine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000924	0.00108	CcSEcCtD
Hydralazine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000917	0.00107	CcSEcCtD
Hydralazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000917	0.00107	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000908	0.00106	CcSEcCtD
Hydralazine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000905	0.00106	CcSEcCtD
Hydralazine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000895	0.00104	CcSEcCtD
Hydralazine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000894	0.00104	CcSEcCtD
Hydralazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000891	0.00104	CcSEcCtD
Hydralazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000891	0.00104	CcSEcCtD
Hydralazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000891	0.00104	CcSEcCtD
Hydralazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000888	0.00104	CcSEcCtD
Hydralazine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000877	0.00102	CcSEcCtD
Hydralazine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00087	0.00102	CcSEcCtD
Hydralazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000866	0.00101	CcSEcCtD
Hydralazine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000863	0.00101	CcSEcCtD
Hydralazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000862	0.00101	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00086	0.001	CcSEcCtD
Hydralazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000855	0.000997	CcSEcCtD
Hydralazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000853	0.000995	CcSEcCtD
Hydralazine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000841	0.000982	CcSEcCtD
Hydralazine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000841	0.000982	CcSEcCtD
Hydralazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00083	0.000969	CcSEcCtD
Hydralazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000827	0.000965	CcSEcCtD
Hydralazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000824	0.000962	CcSEcCtD
Hydralazine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000821	0.000958	CcSEcCtD
Hydralazine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00082	0.000956	CcSEcCtD
Hydralazine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000814	0.00095	CcSEcCtD
Hydralazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000814	0.00095	CcSEcCtD
Hydralazine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000811	0.000946	CcSEcCtD
Hydralazine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000802	0.000936	CcSEcCtD
Hydralazine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0008	0.000934	CcSEcCtD
Hydralazine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000795	0.000928	CcSEcCtD
Hydralazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000794	0.000926	CcSEcCtD
Hydralazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000791	0.000923	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000788	0.000919	CcSEcCtD
Hydralazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000788	0.000919	CcSEcCtD
Hydralazine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000787	0.000918	CcSEcCtD
Hydralazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000782	0.000912	CcSEcCtD
Hydralazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000781	0.000911	CcSEcCtD
Hydralazine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00078	0.00091	CcSEcCtD
Hydralazine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000779	0.000908	CcSEcCtD
Hydralazine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000779	0.000908	CcSEcCtD
Hydralazine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000773	0.000902	CcSEcCtD
Hydralazine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000771	0.0009	CcSEcCtD
Hydralazine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000893	CcSEcCtD
Hydralazine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.000879	CcSEcCtD
Hydralazine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000752	0.000878	CcSEcCtD
Hydralazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000749	0.000874	CcSEcCtD
Hydralazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000749	0.000874	CcSEcCtD
Hydralazine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000745	0.000869	CcSEcCtD
Hydralazine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000744	0.000868	CcSEcCtD
Hydralazine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000737	0.00086	CcSEcCtD
Hydralazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000737	0.000859	CcSEcCtD
Hydralazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000734	0.000857	CcSEcCtD
Hydralazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000733	0.000855	CcSEcCtD
Hydralazine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.000849	CcSEcCtD
Hydralazine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000725	0.000846	CcSEcCtD
Hydralazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000724	0.000844	CcSEcCtD
Hydralazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000722	0.000842	CcSEcCtD
Hydralazine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.000842	CcSEcCtD
Hydralazine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00072	0.00084	CcSEcCtD
Hydralazine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000717	0.000836	CcSEcCtD
Hydralazine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000717	0.000836	CcSEcCtD
Hydralazine—Rash—Vincristine—peripheral nervous system neoplasm	0.000711	0.000829	CcSEcCtD
Hydralazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00071	0.000828	CcSEcCtD
Hydralazine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000826	CcSEcCtD
Hydralazine—Headache—Vincristine—peripheral nervous system neoplasm	0.000706	0.000824	CcSEcCtD
Hydralazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000695	0.00081	CcSEcCtD
Hydralazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000693	0.000808	CcSEcCtD
Hydralazine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000682	0.000795	CcSEcCtD
Hydralazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000673	0.000785	CcSEcCtD
Hydralazine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000669	0.000781	CcSEcCtD
Hydralazine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000668	0.00078	CcSEcCtD
Hydralazine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000666	0.000778	CcSEcCtD
Hydralazine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.000774	CcSEcCtD
Hydralazine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000646	0.000754	CcSEcCtD
Hydralazine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000646	0.000754	CcSEcCtD
Hydralazine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000634	0.000739	CcSEcCtD
Hydralazine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000628	0.000733	CcSEcCtD
Hydralazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000628	0.000732	CcSEcCtD
Hydralazine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000625	0.000729	CcSEcCtD
Hydralazine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000619	0.000722	CcSEcCtD
Hydralazine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000604	0.000704	CcSEcCtD
Hydralazine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000603	0.000703	CcSEcCtD
Hydralazine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.000698	CcSEcCtD
Hydralazine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000592	0.000691	CcSEcCtD
Hydralazine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000679	CcSEcCtD
Hydralazine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00058	0.000677	CcSEcCtD
Hydralazine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000676	CcSEcCtD
Hydralazine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000576	0.000672	CcSEcCtD
Hydralazine—Rash—Etoposide—peripheral nervous system neoplasm	0.000576	0.000672	CcSEcCtD
Hydralazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000575	0.000671	CcSEcCtD
Hydralazine—Headache—Etoposide—peripheral nervous system neoplasm	0.000572	0.000667	CcSEcCtD
Hydralazine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000565	0.00066	CcSEcCtD
Hydralazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000655	CcSEcCtD
Hydralazine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000651	CcSEcCtD
Hydralazine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000646	CcSEcCtD
Hydralazine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000542	0.000633	CcSEcCtD
Hydralazine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000628	CcSEcCtD
Hydralazine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000626	CcSEcCtD
Hydralazine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000623	CcSEcCtD
Hydralazine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000623	CcSEcCtD
Hydralazine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.000622	CcSEcCtD
Hydralazine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000621	CcSEcCtD
Hydralazine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000527	0.000615	CcSEcCtD
Hydralazine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.00061	CcSEcCtD
Hydralazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000606	CcSEcCtD
Hydralazine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000598	CcSEcCtD
Hydralazine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000512	0.000597	CcSEcCtD
Hydralazine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000585	CcSEcCtD
Hydralazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000583	CcSEcCtD
Hydralazine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000576	CcSEcCtD
Hydralazine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000576	CcSEcCtD
Hydralazine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000574	CcSEcCtD
Hydralazine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.000569	CcSEcCtD
Hydralazine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000569	CcSEcCtD
Hydralazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000558	CcSEcCtD
Hydralazine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000552	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000544	CcSEcCtD
Hydralazine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000541	CcSEcCtD
Hydralazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000539	CcSEcCtD
Hydralazine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00046	0.000536	CcSEcCtD
Hydralazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000532	CcSEcCtD
Hydralazine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.000527	CcSEcCtD
Hydralazine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000526	CcSEcCtD
Hydralazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000519	CcSEcCtD
Hydralazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000516	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000515	CcSEcCtD
Hydralazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000511	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000503	CcSEcCtD
Hydralazine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.000496	CcSEcCtD
Hydralazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000492	CcSEcCtD
Hydralazine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000492	CcSEcCtD
Hydralazine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000486	CcSEcCtD
Hydralazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.00048	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000477	CcSEcCtD
Hydralazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000474	CcSEcCtD
Hydralazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000472	CcSEcCtD
Hydralazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000472	CcSEcCtD
Hydralazine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000455	CcSEcCtD
Hydralazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000377	0.00044	CcSEcCtD
Hydralazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000439	CcSEcCtD
Hydralazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000437	CcSEcCtD
Hydralazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000422	CcSEcCtD
Hydralazine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000408	CcSEcCtD
Hydralazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000407	CcSEcCtD
Hydralazine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000395	CcSEcCtD
Hydralazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000391	CcSEcCtD
Hydralazine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000325	0.00038	CcSEcCtD
Hydralazine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000378	CcSEcCtD
Hydralazine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000376	CcSEcCtD
Hydralazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000376	CcSEcCtD
Hydralazine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000374	CcSEcCtD
Hydralazine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000365	CcSEcCtD
Hydralazine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000355	CcSEcCtD
Hydralazine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000351	CcSEcCtD
Hydralazine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000348	CcSEcCtD
Hydralazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000348	CcSEcCtD
Hydralazine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000346	CcSEcCtD
Hydralazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000328	CcSEcCtD
